Federated Hermes’s Acutus Medical Inc AFIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,685
Closed -$340 2169
2023
Q4
$340 Sell
1,685
-52
-3% -$20 ﹤0.01% 2023
2023
Q3
$1.21K Hold
1,737
﹤0.01% 2001
2023
Q2
$1.54K Hold
1,737
﹤0.01% 2006
2023
Q1
$1.31K Sell
1,737
-115
-6% -$150 ﹤0.01% 2030
2022
Q4
$2.13K Hold
1,852
﹤0.01% 2000
2022
Q3
$2K Sell
1,852
-3,082
-62% -$3.73K ﹤0.01% 1992
2022
Q2
$6K Buy
4,934
+881
+22% +$756 ﹤0.01% 1886
2022
Q1
$6K Buy
4,053
+2,217
+121% +$4.74K ﹤0.01% 1946
2021
Q4
$6K Buy
+1,836
New +$10.3K ﹤0.01% 1985

Other funds holding AFIB

Federated Hermes's AFIB Position: Q1 2024 in Review

Federated Hermes sold out of Acutus Medical Inc (AFIB) in Q1 2024, closing a stake of 1,685 shares — an estimated $340 sold.

Federated Hermes first reported a position in AFIB in Q4 2021 and held it in 9 quarters. The position peaked at $6K in Q2 2022. 23 funds tracked by Wall St. Rank hold AFIB as of Q1 2024.

  • Federated Hermes reported no remaining Acutus Medical Inc position as of Q1 2024 after selling out during the quarter.
  • Federated Hermes sold 1,685 Acutus Medical Inc shares in Q1 2024, an estimated $340.
  • Federated Hermes first reported a position in Acutus Medical Inc in Q4 2021 and held it in 9 quarters.
  • Federated Hermes's Acutus Medical Inc position peaked at $6K in Q2 2022.
  • 23 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q1 2024.

Based on Federated Hermes's 13F filing for Q1 2024, filed 14 May 2024.